IDEXX Laboratories (IDXX) director granted 49 deferred stock units
Rhea-AI Filing Summary
IDEXX Laboratories director Joseph L. Hooley acquired 49 deferred stock units of common stock on July 30, 2026 under the company’s Director Deferred Compensation Plan. The grant represents $27,280.22 of deferred cash fees, converted at a closing share price of $558.80 per unit. Each unit equals one IDEXX common share, vests immediately, and will be paid in stock after his board service ends or on other preset dates allowed by the plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 49 shares
Net Buy
1 txn
Insider
HOOLEY JOSEPH L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 49 | $558.80 | $27K |
Holdings After Transaction:
Common Stock — 325 shares (Direct)
Footnotes (1)
- F1. Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the 'Plan') in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($27,280.22) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.
Key Figures
Deferred stock units acquired: 49 units
Deferred cash compensation: $27,280.22
Reference share price: $558.80 per share
+1 more
4 metrics
Deferred stock units acquired
49 units
Non-derivative grant to director on 2026-07-30
Deferred cash compensation
$27,280.22
Board fees converted into deferred stock units under the Director Deferred Compensation Plan
Reference share price
$558.80 per share
IDEXX closing common stock price used to calculate number of deferred stock units
Direct holdings after transaction
325 shares
Reported direct common stock or equivalent units held by Joseph L. Hooley following the grant
Key Terms
deferred stock units, Director Deferred Compensation Plan, Rule 16b-3, contingent right
4 terms
deferred stock units financial
"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Director Deferred Compensation Plan financial
"acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan")"
Rule 16b-3 regulatory
"acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan in accordance with Rule 16b-3"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
contingent right financial
"Each deferred stock unit represents a contingent right to receive one share of IDEXX"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did IDEXX (IDXX) director Joseph L. Hooley report in this Form 4?
Joseph L. Hooley reported acquiring 49 deferred stock units of IDEXX common stock as director compensation. These units were granted under the Director Deferred Compensation Plan and represent board fees that were converted into stock-based units instead of being taken in cash.
How many IDEXX (IDXX) deferred stock units did Hooley receive and what was their value?
Hooley received 49 deferred stock units, based on deferred cash compensation of $27,280.22. The number of units was calculated by dividing those fees by the IDEXX closing share price of $558.80 on the deferral date, then rounding to the nearest whole unit.
What is the IDEXX (IDXX) Director Deferred Compensation Plan mentioned in the filing?
The Director Deferred Compensation Plan allows IDEXX directors to defer cash fees into deferred stock units. Each unit represents a contingent right to receive one IDEXX common share, vests immediately upon grant, and is paid in stock after board resignation or on other preset, nondiscretionary dates.
Were Hooley’s IDEXX (IDXX) deferred stock units granted under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not checked, so this acquisition was not identified as occurring under a Rule 10b5-1 trading plan. Instead, it reflects routine director compensation deferred into stock units under the company’s Director Deferred Compensation Plan.
What is Hooley’s IDEXX (IDXX) common stock position after this grant?
After this transaction, Hooley is reported as directly owning 325 shares or equivalent common stock units. This total includes the newly acquired 49 deferred stock units and reflects his overall direct common stock-related position reported for this security class.